Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHATH: CHIP in Patients Over 75 With First CVE
NCT04581057Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2020
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Presence of a Clonal Hematopoiesis of Indeterminate Potential (CHIP) at Day 1. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT04581057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04581057.